Search Results 431-440 of 7956 for TNF

  1. Simtuzumab (GS-6624) in the Treatment of Cirrhosis Due to NASH - Mayo Clinic

    This study is to evaluate the safety and efficacy of simtuzumab (GS-6624) in adults with compensated cirrhosis due to Non-Alcoholic Steatohepatitis (NASH). It ...

  2. Evaluation of N Latex Beta Trace Protein on BN™ Systems as eGFR and RKF Marker - Mayo Clinic

    About this study. The purpose of this study is to test specific analytical performance characteristics of the beta trace protein (BTP) assay on the BN ...

  3. A Study of Donated Alloantigen Reactive Regulatory T Cells for Reducing or Discontinuing Immune System Suppression in Liver Transplant Patients - Mayo Clinic

    About this study. This research study is for liver transplant recipients and their respective living donors. The purpose of this study is to see if it is ...

  4. A Study to Evaluate the Effect of Medical Intervention on Sinonasal Inflammation in Patients with Chronic Sinusitis, Nasal Polyps and Positive Sinus Culture - Mayo Clinic

    About this study. The purpose of this study is to compare change in SNOT-22 score in patients who received medication therapy such as oral antibiotics, ...

  5. A Study to Evaluate the Process of Aging in Human Atherosclerosis - Mayo Clinic

    The purpose of this study is to critically test the hypothesis that senescent-cell derived factors (cell aging), in particular IGFBP3, suppress the innate ...

  6. Publications - Jonathan A. Leighton, M.D. - Mayo Clinic

    Novel Genetic Risk Variants Can Predict Anti-TNF Agent Response in Patients With Inflammatory Bowel Disease. J Crohns Colitis. 2019 Aug 14; 13 (8):1036-1043

  7. Macroglobulinemia Clinical Trials

    Ibrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Rituximab is a monoclonal antibody that may interfere with ...

  8. MC200404, Safety and Immunogenicity of PolyPEPI1018 Vaccine in the Treatment of Late-stage Metastatic Colorectal Cancer - Mayo Clinic

    However, TAS-102 is FDA approved for treatment of metastatic colorectal cancer. The FDA has allowed the use of this combination in this research study.

  9. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

    The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...

  10. Mayo Clinic Traumatic Brain Injury Model System Center: The CONNECT Trial

    About this study. Mayo Clinic has been funded by the National Institute on Disability & Rehabilitation Research (NIDRR) as a Traumatic Brain Injury (TBI) ...